These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 107313)

  • 21. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu W
    Lancet; 1984 Jun; 1(8389):1297. PubMed ID: 6145002
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Taylor SH
    Lancet; 1984 Jul; 2(8394):97. PubMed ID: 6146027
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of lecithin on percutaneous absorption of drugs. II. Mechanism of enhancing effect of lecithin on the percutaneous absorption of indomethacin gel-ointment].
    Natsuki R; Takabatake E
    Yakugaku Zasshi; 1987 Aug; 107(8):622-6. PubMed ID: 3430335
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of dose and ointment application technique on nitroglycerin plasma concentrations.
    Iafrate RP; Yost RL; Curry SH; Gotz VP; Caranasos GJ
    Pharmacotherapy; 1983; 3(2 Pt 1):118-24. PubMed ID: 6406987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of lecithin on percutaneous absorption of drugs. I. Absorption and excretion of indomethacin gel-ointment through rat back skin].
    Natsuki R; Takabatake E
    Yakugaku Zasshi; 1987 Aug; 107(8):616-21. PubMed ID: 3430334
    [No Abstract]   [Full Text] [Related]  

  • 27. Transcutaneous nitroglycerin--ointment or disc?
    Abrams J
    Am Heart J; 1984 Dec; 108(6):1597-600. PubMed ID: 6439020
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of penetration enhancers on the in-vitro percutaneous absorption of progesterone.
    Valenta C; Wedenig S
    J Pharm Pharmacol; 1997 Oct; 49(10):955-9. PubMed ID: 9364402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethanol: water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin.
    Berner B; Mazzenga GC; Otte JH; Steffens RJ; Juang RH; Ebert CD
    J Pharm Sci; 1989 May; 78(5):402-7. PubMed ID: 2501473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bioavailability of glycerol trinitrate (nitroglycerin) from an ointment preparation].
    Gielsdorf W; Schlegel E; Settlage JA; Jaeger H; Fink E
    Arzneimittelforschung; 1983; 33(12):1677-9. PubMed ID: 6421295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of a new transdermal nitroglycerin adhesive patch formulation.
    Riedel DJ; Wick KA; Hawkinson RW; Kolars CA; Crowley JK; Armstrong KE; Chang SF; Harrison LI; de Dennis SR
    Clin Ther; 1989; 11(2):225-31. PubMed ID: 2500248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of limonene and laurocapram on percutaneous absorption of nonsteroidal anti-inflammatory drugs.
    Priborský J; Takayama K; Obata Y; Príborská Z; Nagai T
    Arzneimittelforschung; 1992 Feb; 42(2):116-9. PubMed ID: 1610418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vehicle effects in percutaneous absorption: in vitro study of influence of solvent power and microscopic viscosity of vehicle on benzocaine release from suspension hydrogels.
    Di Colo G; Carelli V; Giannaccini B; Serafini MF; Bottari F
    J Pharm Sci; 1980 Apr; 69(4):387-91. PubMed ID: 7373530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Percutaneous absorption of drug from alpha-olefin oligomer gel bases].
    Kaiho F; Hirose C; Shimizu A; Sunada K; Isoyama A; Miyazaki K; Dohi M; Kato Y
    Yakugaku Zasshi; 1992 Mar; 112(3):193-8. PubMed ID: 1608043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes.
    Okabe H; Obata Y; Takayama K; Nagai T
    Drug Des Deliv; 1990 Sep; 6(3):229-38. PubMed ID: 2076182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of diethyl-beta-cyclodextrin on the release of nitroglycerin from formulations.
    Umemura M; Ueda H; Tomono K; Nagai T
    Drug Des Deliv; 1990 Oct; 6(4):297-310. PubMed ID: 2128021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and Antiinflammatory Effect of a Novel Gel System Containing Ketoprofen Solid Nanoparticles.
    Nagai N; Iwamae A; Tanimoto S; Yoshioka C; Ito Y
    Biol Pharm Bull; 2015; 38(12):1918-24. PubMed ID: 26632183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the in-vitro percutaneous penetration of indomethacin from gel systems in hairless mice.
    Liu CH; Ho HO; Hsieh MC; Sokoloski TD; Sheu MT
    J Pharm Pharmacol; 1995 May; 47(5):365-72. PubMed ID: 7494184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu WC; Stevens JL
    Clin Pharmacol Ther; 1984 Dec; 36(6):765-72. PubMed ID: 6437723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous absorption of ibuprofen from different formulations. Comparative study with gel, hydrophilic ointment and emulsion cream.
    Seth PL
    Arzneimittelforschung; 1993 Aug; 43(8):919-21. PubMed ID: 8216453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.